For the Inventor, By the Inventor

Enter assignee name

Emeryville, CA, United States of America

Crystal Bioscience Inc.

USPTO Granted Patents = 25

CIPO Patents = 13

EPO Patents = 4

Trademarks = 10

Forward Citations = 124

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

William Don Harriman (23 out of 29 patents)

Robert Etches (16 out of 21 patents)

Philip A Leighton (13 out of 14 patents)

4. Phil Leighton (3 out of 3 patents)

5. Marie-Cecile Van De Lavoir (2 out of 3 patents)

6. Shelley Izquierdo (1 out of 4 patents)

7. Christel Iffland (1 out of 7 patents)

8. Ellen Collarini (1 out of 1 patent)

25 patents: Sort by Forward Citations

1. 12441802 - Anti-B7-H3 antibody and methods of use thereof (2025-10-14),

2. 12428471 - Transgenic chicken that makes antibodies with long CDR-H3S stabilized by multiple disulfide bridges and diversified by gene conversion (2025-09-30),

3. 12408640 - Transgenic animal for producing diversified antibodies that have the same light chain I (2025-09-09),

4. 12102070 - Camelization of a human variable domain by gene conversion (2024-10-01),

5. 11602136 - In vivo method for generating diversity in a protein scaffold (2023-03-14),

6. 11542319 - Transgenic chicken comprising an inactivated immunoglobulin gene (2023-01-03),

7. 11337409 - Transgenic animal for producing diversified antibodies that have the same light chain I (2022-05-24),

8. 11033009 - Transgenic chicken for production of antibodies having a common light chain (2021-06-15),

9. 10689433 - Transgenic chicken comprising an inactivated immunoglobulin gene (2020-06-23),

10. 10687519 - Transgenic animal for production of antibodies having minimal CDRs (2020-06-23),

11. 10555508 - In vivo method for generating diversity in a protein scaffold (2020-02-11),

12. 10362770 - Transgenic animal for production of antibodies having minimal CDRs (2019-07-30),

13. 10172334 - Transgenic animal for production of antibodies having minimal CDRS (2019-01-08),

14. 10010058 - Transgenic animal for production of antibodies having minimal CDRS (2018-07-03),

15. 9982062 - In vivo method for generating diversity in a protein scaffold (2018-05-29),

Crystal Bioscience Inc. is a biotechnology company specializing in the discovery and development of novel antibody therapeutics. With a focus on delivering innovative solutions for unmet medical needs, Crystal Bioscience leverages advanced technologies to identify and optimize antibodies with high therapeutic potential. Through their cutting-edge platform, Crystal Bioscience aims to accelerate the development of breakthrough treatments for various diseases including cancer, autoimmune disorders, and infectious diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

25 Patents

#24 in Emeryville, CA

#3,056 in California

#12,903 in US

#24,910 in the World

Emeryville, CA, United States of America

Crystal Bioscience Inc.

Forward Citations = 124

8 inventors:

William Don Harriman (23 out of 29 patents)

Robert Etches (16 out of 21 patents)

Philip A Leighton (13 out of 14 patents)

4. Phil Leighton (3 out of 3 patents)

5. Marie-Cecile Van De Lavoir (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…